Physician

Jay Prochnau, MD

According to 2025 Medicare claims, Jay Prochnau, MD (NPI: 1366411878) practices allergy/immunology in the Lafayette-West Lafayette, IN market, with the plurality of this provider's patient population coming from Tippecanoe, IN. This provider's primary affiliated billing organization is ARNETT CLINIC, LLC (NPI: 1164490843; TIN: 352030653) and primary practice location at 47904-3055. Prochnau is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550) and Indiana University Health ACO, Inc. (ACO ID: D0034), participating under both the MSSP and REACH models.

Prochnau's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 263 traditional Medicare patients, billed 11,018 HCPCS/CPT codes, and received $252,268 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,592 prescription claims across 313 beneficiaries totaling $841,544 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 175 claims. Open Payments data shows 4 records totaling $270. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $288,417 to $252,268. In contrast, Part D prescription costs have moved sharply higher in recent years, from $180,890 to $841,544. For DME billing, this smaller-volume category declined steadily, from $13,218 to $4,227.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	235	15,411	$288,417
2016	303	18,577	$377,652
2017	300	18,623	$396,118
2018	277	13,689	$302,981
2019	285	13,838	$308,651
2020	245	11,040	$274,523
2021	263	11,565	$271,653
2022	285	11,506	$263,526
2023	262	9,291	$204,041
2024	263	11,018	$252,268

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	162	1,282	$180,890
2016	254	1,789	$259,454
2017	245	2,044	$371,711
2018	241	1,979	$399,826
2019	260	2,035	$460,793
2020	264	2,143	$552,178
2021	279	2,081	$698,882
2022	292	2,336	$702,920
2023	296	2,384	$885,530
2024	313	2,592	$841,544

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	451	$38,186
2016	43	500	$40,515
2017	48	579	$42,796
2018	50	546	$52,047
2019	19	483	$40,067
2020	18	432	$39,097
2021	15	376	$32,399
2022	16	376	$19,839
2023	19	334	$17,400
2024	12	175	$8,281

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	38	38	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	187	310	$87
94010	Test to measure expiratory airflow and volume	78	82	$18
95165	Professional service for preparation and provision of 1 or more antigens	39	1,510	$10
95117	Professional service for multiple injections of allergen	50	410	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	55	1,694	$245,609
Xolair	Omalizumab	42	1,176	$129,775
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	136	4,740	$99,205
Breo Ellipta	Fluticasone/Vilanterol	90	3,810	$48,041
Advair Hfa	Fluticasone Propion/Salmeterol	53	2,964	$35,932

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	18	$2,638
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	22	$2,120
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	34	$2,018
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	12	40	$939
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	19	$239

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$270	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jay Prochnau, MD?

Tedicare shows public-source Medicare data for Jay Prochnau, MD (NPI 1366411878), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jay Prochnau, MD have ACO affiliation data?

Jay Prochnau, MD is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550) and Indiana University Health ACO, Inc. (REACH, ACO ID D0034).

What billing organization is linked to Jay Prochnau, MD?

Jay Prochnau, MD is linked to ARNETT CLINIC, LLC (billing NPI 1164490843) in the available physician profile data.

Does Jay Prochnau, MD have Open Payments data?

Jay Prochnau, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.